Alabama Genetic Testing Program Closes Enrollment
Catalyst tested more than 9,300 residents at home, and its enrollment could reopen only if new funding arrives.
Updated on Nov. 2, 2026 in Life Sciences
Live Poll
Should state and local governments fund free genetic testing programs for residents?
Southern Research's Catalyst program provided free clinical genetic testing to more than 9,300 participants across all 67 Alabama counties, returning more than 5,600 clinical genetic results. Enrollment closed September 30 as the program's current grant period ended; the program is a completed, past-tense effort rather than an ongoing offering.
Why it matters
The program used a mail-in cheek-swab model, letting residents be tested at home instead of traveling to a medical center, and it tied inherited-risk results to pharmacogenetic information on more than 70 common medications. Its funding came from state and Birmingham grants, and its closure shows how dependent such statewide genetic screening is on time-limited public money.
Program figures from Southern Research count 9,300-plus participants tested and 5,600-plus clinical genetic results returned, with 400-plus community events attended. The stub reports no comparator baseline and does not state how many enrolled participants have yet to return samples.
The players
Southern Research
A nonprofit research organization that ran the Catalyst program, which combined at-home genetic testing with community outreach.
Birmingham
The Alabama city whose grant helped fund the Catalyst program alongside state money.
The details
Catalyst mailed cheek-swab kits to participants' homes, and participants returned their samples by mail for analysis. The testing examined selected inherited risks for heart disease, type 2 diabetes and certain cancers. Participants also received information on how their genes may affect their response to more than 70 common medications, a field called pharmacogenetics, which studies how inherited variation changes drug effects.
Timeline
The Catalyst program launched in October 2024.
Enrollment closed September 30 as Southern Research's grant period ended.
Enrolled participants who have not returned samples have 90 days from their order date to do so.
The Tech Race
Catalyst's mail-order, cheek-swab model is a population-scale variant of clinical genetic screening that usually happens inside medical centers. The stub offers no comparison to other state or national screening programs, so its position within the wider field cannot be measured.
Enrollment in Catalyst is closed, so new participants cannot currently join this program, and the stub gives no date for any reopening. Enrolled participants who have not yet mailed their samples have 90 days from their order date to return them.
The takeaway
Watch whether Southern Research or state officials announce additional funding that could reopen Catalyst enrollment. For anyone who ordered a kit, return the sample within its 90-day window.
Further reading
For broader context on how genetic testing reaches patients, browse Life Sciences coverage.
Source note: This article includes information reported by Yellowhammer News.
Live Poll
Should state and local governments fund free genetic testing programs for residents?
